Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-26Clinical Trial Update: Study Testing Convalescent Plasma vs Best Supportive Care [Phase 1]
A Phase 1 trial evaluating convalescent plasma versus best supportive care for interstitial pneumonia has been withdrawn. The sponsor is Bay…
-
CLINICAL_TRIALS withdrawal · 2025-12-02Clinical Trial Update: Validation of Aspiration Markers in Intubated Patients [Phase 1]
Phase 1 trial validating aspiration markers in intubated patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009) [Phase 1]
The Phase 1 trial of Frespaciguat (MK-5475) in participants with hypoxemia due to COVID-19 pneumonia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-30Clinical Trial Update: Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias [Phase 1]
Phase 1 trial of mesenchymal stromal cells for COVID-19 pneumonia and viral pneumonia has been withdrawn. Sponsor: Medical University of Sou…
-
CLINICAL_TRIALS withdrawal · 2024-04-26Clinical Trial Update: Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) [Phase 2]
A Phase 2 trial evaluating jaktinib for severe COVID-19 pneumonia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-12-21Clinical Trial Update: Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection [Phase 3]
Phase 3 trial comparing Aralast NP with antiviral treatment and standard care versus antiviral treatment with standard care in hospitalized …
-
EMA withdrawal · 2020-02-05EMA Application withdrawn: Nuzyra — Paratek Ireland Limited
The EMA status shows withdrawal of the Nuzyra application by Paratek Ireland Limited.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation [Phase 2, Phase 3]
Trial update indicates the Phase 2/Phase 3 study comparing high frequency percussive ventilation with conventional ventilation for adult res…
-
CLINICAL_TRIALS withdrawal · 2018-03-27Clinical Trial Update: Pneumonia Chart Review Cambodia
A pneumonia chart review trial conducted in Cambodia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions [Phase 1]
A Phase 1 bioequivalence study comparing SKF101804 cefixime to a cefixime reference formulation in healthy adults under fasting conditions h…
-
EMA withdrawal · 2017-06-02EMA Application withdrawn: Solithromycin Triskel EU Services (solithromycin) — Triskel EU Services Ltd
The EMA reports withdrawal of the Solithromycin application by Triskel EU Services Ltd for uses including tularemia, pneumonia, and anthrax.
-
CLINICAL_TRIALS withdrawal · 2016-08-31Clinical Trial Update: Reducing Cost of Azythromycin by Transferring From IV to Oral Therapy [NA]
A clinical trial evaluating cost reduction by switching from intravenous to oral azithromycin for pneumonia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-19Clinical Trial Update: EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients
A clinical trial evaluating the EarlySense monitoring device in patients with COPD, congestive heart failure, and pneumonia has been withdra…
-
CLINICAL_TRIALS withdrawal · 2016-03-16Clinical Trial Update: Validation of Aspiration Markers [Phase 1]
Phase 1 trial to validate aspiration biomarkers for aspiration pneumonia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-25Clinical Trial Update: A Polymerase Chain Reaction (PCR) - Based Method to Improve Antibiotic Prescribing for Pneumonia
A trial evaluating a PCR-based method to guide antibiotic prescribing for pneumonia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-18Clinical Trial Update: Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization [Phase 2]
A Phase 2 trial evaluating aerosolized amikacin and fosfomycin in mechanically ventilated patients with Gram-negative and/or Gram-positive b…
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: Evaluation of Lung Doppler Signals in Patients Presenting to EMD
A clinical trial evaluating lung Doppler signals in patients presenting with acute cardiovascular conditions and pneumonia has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2015-07-28Clinical Trial Update: Outpatient Registry Trial of Respiratory Tract Infections in Adults [Phase 4]
This document reports the withdrawal of an outpatient registry trial for respiratory tract infections in adults (Phase 4). The study focused…
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Levviax (telithromycin) — Aventis Pharma S.A.
Telithromycin (Levviax) has been withdrawn from the market by Aventis Pharma S.A. for community-acquired infections including pharyngitis, b…
-
EMA withdrawal · 2007-07-26EMA Application withdrawn: Garenoxacin mesylate — Schering-Plough Europe
The EMA application for garenoxacin mesylate by Schering-Plough Europe was withdrawn.